Business
Re Director Dealings
Re Director Dealings.
About this update from Futura Medical Plc
[{"type":"text","content":"\n RNS Number : 1580G Futura Medical PLC 26 January 2010 \n \n \n\n\n\n\n\nFor immediate release\n\n\n26 January 2010\n\n\n\n\n\n\n\nFutura Medical plc\n(\"Futura\" or \"the Company\")\n\n Correction of Director's Dealings\n\nFutura Medical plc (AIM: FUM) announces a correction to its director's dealing announcement of 17 December 2009 (the \"Original Announcement\"). \n\nIn the Original Announcement James Barder's aggregate beneficial and non-beneficial holdings was described as \"unchanged at 720,212 ordinary shares\". This number should have been stated as \"unchanged at 845,212 ordinary shares\". This is a correction and does not reflect any change to Mr Barder's actual holding.\n\n\nFor any further information please contact:\n\n\n\n\n\nFutura Medical plc\n\n\n\n\n\n\n\nJames Barder, Chief Executive\n\n\nTel: +44 (0) 1483 685 670\n\n\n\n\n\n\n\n\n\n\n\n\nmail to: [email protected] \n\n\nwww.futuramedical.com \n\n\n\n\n\n\n\n\n\n\n\n\nNomura Code Securities Limited \n\n\n\n\n\n\n\nPhil Walker / Giles Balleny\n\n\nTel:+44 (0)20 7776 1200\n\n\n\n\n\n\n\n\n\n\n\n\nFor media enquiries please contact: \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBuchanan Communications\n\n\n\n\n\n\n\nMark Court / Stasa Filiplic / Jennie Spivey\n\n\nTel: +44 (0) 20 7466 5000\n\n\n\n\n\n\nNotes to Editors\n\nFutura Medical plc\n\nFutura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.\n\nFutura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.\n \nwww.futuramedical.com \n\n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END MSCPGUUUGUPUGQQ \n ","length":5666,"tagName":"div"}]